{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:18:02Z","timestamp":1789564682978,"version":"build-2803163510"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40266-025-01276-4","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:03:50Z","timestamp":1769105030000},"page":"123-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Methotrexate for Osteoarthritis: What Does the Evidence Say?"],"prefix":"10.1007","volume":"43","author":[{"given":"Marina","family":"De Castro Fidalgo E Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Ponchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kierran","family":"Flack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Conaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9917-1269","authenticated-orcid":false,"given":"Sarah R.","family":"Kingsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"1276_CR1","unstructured":"Institute for Health Metrics and Evaluation. Explore results from the 2019 Global Burden of Disease (GBD) study: Institute for Health Metrics and Evaluation; 2019. Available from: http:\/\/ghdx.healthdata.org\/gbd-results-tool."},{"issue":"9","key":"1276_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/art.24021","volume":"59","author":"L Murphy","year":"2008","unstructured":"Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Care Res. 2008;59(9):1207\u201313.","journal-title":"Arthritis Care Res"},{"issue":"9","key":"1276_CR3","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","volume":"5","author":"JD Steinmetz","year":"2023","unstructured":"Steinmetz JD, Culbreth GT, Haile LM, Rafferty Q, Lo J, Fukutaki KG, et al. Global, regional, and national burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Rheumatology. 2023;5(9):e508\u201322.","journal-title":"The Lancet Rheumatology."},{"issue":"3","key":"1276_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2105\/AJPH.84.3.351","volume":"84","author":"AA Guccione","year":"1994","unstructured":"Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84(3):351\u20138.","journal-title":"Am J Public Health"},{"key":"1276_CR5","doi-asserted-by":"crossref","unstructured":"Tang SA, Zhang C, Oo WM, Fu K, Risberg MA, Bierma-Zeinstra SM, et al. Osteoarthritis. Nat Rev Dis Primers. 2025;11(1).","DOI":"10.1038\/s41572-025-00594-6"},{"issue":"1","key":"1276_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","volume":"21","author":"F Berenbaum","year":"2013","unstructured":"Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16\u201321.","journal-title":"Osteoarthritis Cartilage"},{"key":"1276_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-025-04976-5","author":"F Berenbaum","year":"2025","unstructured":"Berenbaum F. Recent developments in pharmacologic therapy of synovitis in osteoarthritis. Skeletal Radiol. 2025. https:\/\/doi.org\/10.1007\/s00256-025-04976-5.","journal-title":"Skeletal Radiol"},{"issue":"5","key":"1276_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.joca.2006.10.010","volume":"15","author":"AD Pearle","year":"2007","unstructured":"Pearle AD, Scanzello CR, George S, Mandl LA, Dicarlo EF, Peterson M, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthr Cartil. 2007;15(5):516\u201323.","journal-title":"Osteoarthr Cartil"},{"issue":"5","key":"1276_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/1759720X12455959","volume":"4","author":"JW Smith","year":"2012","unstructured":"Smith JW, Martins TB, Gopez E, Johnson T, Hill HR, Rosenberg TD. Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes. Ther Adv Musculoskelet Dis. 2012;4(5):315\u201325.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"6","key":"1276_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jbspin.2018.12.005","volume":"86","author":"A Courties","year":"2019","unstructured":"Courties A, Berenbaum F, Sellam J. The phenotypic approach to osteoarthritis: a look at metabolic syndrome-associated osteoarthritis. Jt Bone Spine. 2019;86(6):725\u201330.","journal-title":"Jt Bone Spine"},{"issue":"10","key":"1276_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580\u201392.","journal-title":"Nat Rev Rheumatol"},{"issue":"13","key":"1276_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJM198503283121303","volume":"312","author":"ME Weinblatt","year":"1985","unstructured":"Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med. 1985;312(13):818\u201322.","journal-title":"N Engl J Med"},{"issue":"7","key":"1276_CR13","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/ard.2008.092668","volume":"68","author":"K Visser","year":"2009","unstructured":"Visser K, Van Der Heijde D. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann Rheum Dis. 2009;68(7):1094\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1276_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrrheum.2015.8","volume":"11","author":"JS Smolen","year":"2015","unstructured":"Smolen JS, Aletaha D. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nat Rev Rheumatol. 2015;11(5):276\u201389.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1276_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/rheumatology\/keu279","volume":"54","author":"CF Spurlock","year":"2015","unstructured":"Spurlock CF, Gass HM, Bryant CJ, Wells BC, Olsen NJ, Aune TM. Methotrexate-mediated inhibition of nuclear factor \u03baB activation by distinct pathways in T cells and fibroblast-like synoviocytes. Rheumatology. 2015;54(1):178\u201387.","journal-title":"Rheumatology"},{"issue":"1","key":"1276_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.semarthrit.2013.01.002","volume":"43","author":"KJ Aaltonen","year":"2013","unstructured":"Aaltonen KJ, Virkki LM, J\u00e4msen E, Sokka T, Konttinen YT, Peltomaa R, et al. Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study. Semin Arthritis Rheum. 2013;43(1):55\u201362.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"1276_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/acr.22596","volume":"67","author":"S Asai","year":"2015","unstructured":"Asai S, Kojima T, Oguchi T, Kaneko A, Hirano Y, Yabe Y, et al. Effects of concomitant methotrexate on large joint replacement in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a multicenter retrospective cohort study in Japan. Arthritis Care Res. 2015;67(10):1363\u201370.","journal-title":"Arthritis Care Res"},{"issue":"12","key":"1276_CR18","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.3899\/jrheum.150410","volume":"42","author":"S Asai","year":"2015","unstructured":"Asai S, Takahashi N, Funahashi K, Yoshioka Y, Takemoto T, Terabe K, et al. Concomitant methotrexate protects against total knee arthroplasty in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. J Rheumatol. 2015;42(12):2255\u201360.","journal-title":"J Rheumatol"},{"key":"1276_CR19","doi-asserted-by":"crossref","unstructured":"Weinblatt ME. Methotrexate: who would have predicted its importance in rheumatoid arthritis? Arthritis Res Ther. 2018;20(1).","DOI":"10.1186\/s13075-018-1599-7"},{"issue":"1","key":"1276_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","volume":"13","author":"BN Cronstein","year":"2017","unstructured":"Cronstein BN, Sitkovsky M. Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat Rev Rheumatol. 2017;13(1):41\u201351.","journal-title":"Nat Rev Rheumatol"},{"key":"1276_CR21","doi-asserted-by":"crossref","unstructured":"Bergstr\u00f6m B, Carlsten H, Ekwall A-KH. Methotrexate inhibits effects of platelet-derived growth factor and interleukin-1\u03b2 on rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Res Ther. 2018;20(1).","DOI":"10.1186\/s13075-018-1554-7"},{"issue":"12","key":"1276_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","volume":"12","author":"PM Brown","year":"2016","unstructured":"Brown PM, Pratt AG, Isaacs JD. Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol. 2016;12(12):731\u201342.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1276_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/1529-0131(200003)43:3<656::AID-ANR23>3.0.CO;2-H","volume":"43","author":"MC Montesinos","year":"2000","unstructured":"Montesinos MC, Yap JS, Desai A, Posadas I, McCrary CT, Cronstein BN. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant. Arthritis Rheum. 2000;43(3):656.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1276_CR24","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/art.30457","volume":"63","author":"CF Spurlock","year":"2011","unstructured":"Spurlock CF, Aune ZT, Tossberg JT, Collins PL, Aune JP, Huston JW, et al. Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. Arthritis Rheum. 2011;63(9):2606\u201316.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1276_CR25","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/art.34342","volume":"64","author":"CF Spurlock","year":"2012","unstructured":"Spurlock CF, Tossberg JT, Fuchs HA, Olsen NJ, Aune TM. Methotrexate increases expression of cell cycle checkpoint genes via JNK activation. Arthritis Rheum. 2012;64(6):1780\u20139.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1276_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/JLB.5RU0519-145R","volume":"106","author":"E Gremese","year":"2019","unstructured":"Gremese E, Alivernini S, Tolusso B, Zeidler MP, Ferraccioli G. JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy. J Leukoc Biol. 2019;106(5):1063\u20138.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1276_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/ar4444","volume":"16","author":"NJ Olsen","year":"2014","unstructured":"Olsen NJ, Spurlock CF, Aune TM. Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937. Arthritis Res Ther. 2014;16(1):R17.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"1276_CR28","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1172\/JCI116884","volume":"92","author":"BN Cronstein","year":"1993","unstructured":"Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993;92(6):2675\u201382.","journal-title":"J Clin Invest"},{"key":"1276_CR29","doi-asserted-by":"crossref","unstructured":"De Andres MC, Perez-Pampin E, Calaza M, Santaclara FJ, Ortea I, Gomez-Reino JJ, Gonzalez A. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate. Arthritis Res Ther. 2015;17(1).","DOI":"10.1186\/s13075-015-0748-5"},{"issue":"7","key":"1276_CR30","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/art.1780330706","volume":"33","author":"G Nesher","year":"1990","unstructured":"Nesher G, Moore TL. The in vitro effects of methotrexate on peripheral blood mononuclear cells: modulation by methyl donors and spermidine. Arthritis Rheum. 1990;33(7):954\u20139.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1276_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/ard.50.9.637","volume":"50","author":"G Nesher","year":"1991","unstructured":"Nesher G, Moore TL, Dorner RW. In vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine. Ann Rheum Dis. 1991;50(9):637\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1276_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2119\/molmed.2011.00048","volume":"18","author":"Y-C Wang","year":"2012","unstructured":"Wang Y-C, Chiang E-PI. Low-dose methotrexate inhibits methionine s-adenosyltransferase in vitro and in vivo. Mol Med. 2012;18(3):423\u201332.","journal-title":"Mol Med"},{"issue":"21","key":"1276_CR33","first-page":"5879","volume":"49","author":"JEH Broxson","year":"1989","unstructured":"Broxson JEH, Stork LC, Allen RH, Stabler SP, Kolhouse JF. Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions. Cancer Res. 1989;49(21):5879\u201383.","journal-title":"Cancer Res"},{"issue":"6","key":"1276_CR34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.joca.2025.02.786","volume":"33","author":"W Wong","year":"2025","unstructured":"Wong W, Huang Y, Wichienwantana N, Sun H, Pang J, Shi Y. Efficacy and safety of methotrexate in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2025;33(6):680\u201391.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"1276_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10787-024-01604-x","volume":"33","author":"I Queiroz","year":"2025","unstructured":"Queiroz I, Pimentel T, Gallo Ruelas M, Tavares AH, Barbosa LM, Defante MLR, et al. Methotrexate for osteoarthritis: a systematic review meta-analysis of randomized controlled trials. Inflammopharmacology. 2025;33(1):135\u201344.","journal-title":"Inflammopharmacology"},{"issue":"7","key":"1276_CR36","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/jamainternmed.2025.1359","volume":"185","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Yu Q, Leng X, Xu J, Ren L, Wang K, et al. Low-dose methotrexate for the treatment of inflammatory knee osteoarthritis. JAMA Intern Med. 2025;185(7):808.","journal-title":"JAMA Intern Med"},{"key":"1276_CR37","volume":"65","author":"KPAPM Olej\u00e1rov\u00e1","year":"2006","unstructured":"Olej\u00e1rov\u00e1 KPAPM. Methotrexate in the treatment of the erosive osteoarthrosis of the hands. Ann Rheum Dis. 2006;65:402.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1276_CR38","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/rheumatology\/kes386","volume":"52","author":"CYJ Wenham","year":"2013","unstructured":"Wenham CYJ, Grainger AJ, Hensor EMA, Caperon AR, Ash ZR, Conaghan PG. Methotrexate for pain relief in knee osteoarthritis: an open-label study. Rheumatology. 2013;52(5):888\u201392.","journal-title":"Rheumatology"},{"issue":"3","key":"1276_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.joca.2020.10.004","volume":"29","author":"BR Da Costa","year":"2021","unstructured":"Da Costa BR, Saadat P, Basciani RM, Agarwal A, Johnston BC, J\u00fcni P. Visual analogue scale has higher assay sensitivity than WOMAC pain in detecting between-group differences in treatment effects: a meta-epidemiological study. Osteoarthritis Cartilage. 2021;29(3):304\u201312.","journal-title":"Osteoarthritis Cartilage"},{"issue":"10414","key":"1276_CR40","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(23)01572-6","volume":"402","author":"Y Wang","year":"2023","unstructured":"Wang Y, Jones G, Keen HI, Hill CL, Wluka AE, Kasza J, et al. Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial. Lancet. 2023;402(10414):1764\u201372.","journal-title":"Lancet"},{"issue":"5","key":"1276_CR41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1590\/S0482-50042007000500008","volume":"47","author":"HT de Holanda","year":"2007","unstructured":"de Holanda HT, Pollak DF, Pucinelli MLC. Low-dose methotrexate compared to placebo in the treatment of knee osteoarthritis. Rev Bras Reumatol. 2007;47(5):334\u201340.","journal-title":"Rev Bras Reumatol"},{"issue":"9","key":"1276_CR42","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.7326\/M24-0303","volume":"177","author":"SR Kingsbury","year":"2024","unstructured":"Kingsbury SR, Tharmanathan P, Keding A, Watt FE, Scott DL, Roddy E, et al. Pain reduction with oral methotrexate in knee osteoarthritis. Ann Intern Med. 2024;177(9):1145\u201356.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1276_CR43","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.semarthrit.2021.04.016","volume":"51","author":"S Ferrero","year":"2021","unstructured":"Ferrero S, Wittoek R, Allado E, Cruzel C, Fontas E, Breuil V, et al. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum. 2021;51(4):831\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"1276_CR44","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1136\/ard.2010.128504","volume":"69","author":"R Wittoek","year":"2010","unstructured":"Wittoek R, Carron P, Verbruggen G. Structural and inflammatory sonographic findings in erosive and non-erosive osteoarthritis of the interphalangeal finger joints. Ann Rheum Dis. 2010;69(12):2173\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1276_CR45","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/ard.2009.112714","volume":"69","author":"G Verbruggen","year":"2010","unstructured":"Verbruggen G, Wittoek R, Cruyssen BV, Elewaut D. Morbid anatomy of \u2018erosive osteoarthritis\u2019 of the interphalangeal finger joints: an optimised scoring system to monitor disease progression in affected joints. Ann Rheum Dis. 2010;69(5):862\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1276_CR46","unstructured":"Haldar S and Saha, M. Comparison of methotrexate and glucosamine in primary knee osteoarthritis with inflammation. American College of Rheumatology. 2020."},{"key":"1276_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-025-00466-2","author":"HS Nalwa","year":"2025","unstructured":"Nalwa HS, Barwal TS, Chugh P, Singh N, Jain N, Duggal L, et al. High prevalence of methotrexate intolerance in rheumatoid arthritis patients: a cross-sectional study. BMC Rheumatol. 2025. https:\/\/doi.org\/10.1186\/s41927-025-00466-2.","journal-title":"BMC Rheumatol"},{"issue":"7","key":"1276_CR48","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, Van Der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis. 2009;68(7):1100\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1276_CR49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/BOR.0000000000000923","volume":"35","author":"AJ Knights","year":"2023","unstructured":"Knights AJ, Redding SJ, Maerz T. Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr Opin Rheumatol. 2023;35(2):128\u201334.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"1276_CR50","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.joca.2021.03.008","volume":"29","author":"X Xie","year":"2021","unstructured":"Xie X, Van Delft MAM, Shuweihdi F, Kingsbury SR, Trouw LA, Doody GM, et al. Auto-antibodies to post-translationally modified proteins in osteoarthritis. Osteoarthritis Cartilage. 2021;29(6):924\u201333.","journal-title":"Osteoarthritis Cartilage"},{"issue":"11","key":"1276_CR51","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.joca.2015.06.018","volume":"23","author":"F Ponchel","year":"2015","unstructured":"Ponchel F, Burska AN, Hensor EMA, Raja R, Campbell M, Emery P, et al. Changes in peripheral blood immune cell composition in\u00a0osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1870\u20138.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"1276_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00256-018-3010-9","volume":"48","author":"KJD Steer","year":"2019","unstructured":"Steer KJD, Bostick GP, Woodhouse LJ, Nguyen TT, Schankath A, Lambert RGW, et al. Can effusion-synovitis measured on ultrasound or MRI predict response to intra-articular steroid injection in hip osteoarthritis? Skeletal Radiol. 2019;48(2):227\u201337.","journal-title":"Skeletal Radiol"},{"key":"1276_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1691-1","author":"V Swaminathan","year":"2017","unstructured":"Swaminathan V, Parkes MJ, Callaghan MJ, O\u2019Neill TW, Hodgson R, Gait AD, et al. With a biomechanical treatment in knee osteoarthritis, less knee pain did not correlate with synovitis reduction. BMC Musculoskelet Disord. 2017. https:\/\/doi.org\/10.1186\/s12891-017-1691-1.","journal-title":"BMC Musculoskelet Disord"},{"key":"1276_CR54","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.joca.2025.02.203","volume":"33","author":"J Liang","year":"2025","unstructured":"Liang J, Papadaki A, Alderson J, Vincent T, Conaghan PG, Kingsbury SR, et al. Are there systemic biomarkers of treatment response to methotrexate in people with painful knee osteoarthritis? A biological substudy from the PROMOTE randomised controlled clinical trial. Osteoarthritis Cartilage. 2025;33:S147.","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"1276_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219980","volume":"14","author":"JPM Blair","year":"2019","unstructured":"Blair JPM, Bager C, Platt A, Karsdal M, Bay-Jensen AC. Identification of pathological RA endotypes using blood-based biomarkers reflecting tissue metabolism. A retrospective and explorative analysis of two phase III RA studies. PLoS ONE. 2019;14(7):e0219980.","journal-title":"PLoS ONE"},{"issue":"4","key":"1276_CR56","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.semarthrit.2013.07.008","volume":"43","author":"AC Bay-Jensen","year":"2014","unstructured":"Bay-Jensen AC, Platt A, Byrjalsen I, Vergnoud P, Christiansen C, Karsdal MA. Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study. Semin Arthritis Rheum. 2014;43(4):470\u20138.","journal-title":"Semin Arthritis Rheum"},{"key":"1276_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0913-x","author":"AC Bay-Jensen","year":"2016","unstructured":"Bay-Jensen AC, Platt A, Siebuhr AS, Christiansen C, Byrjalsen I, Karsdal MA. Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study. Arthritis Res Ther. 2016. https:\/\/doi.org\/10.1186\/s13075-015-0913-x.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1276_CR58","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1136\/annrheumdis-2018-213202","volume":"77","author":"M Kloppenburg","year":"2018","unstructured":"Kloppenburg M, Ramonda R, Bobacz K, Kwok W-Y, Elewaut D, Huizinga TWJ, et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2018;77(12):1757\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1276_CR59","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/ard.2011.149849","volume":"71","author":"G Verbruggen","year":"2012","unstructured":"Verbruggen G, Wittoek R, Cruyssen BV, Elewaut D. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis. 2012;71(6):891\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1276_CR60","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.2147\/JIR.S318540","volume":"14","author":"Y Yamanashi","year":"2021","unstructured":"Yamanashi Y, Ohmichi M, Ohmichi Y, Ikemoto T, Arai Y, Maruyama Y, et al. Efficacy of methotrexate on rat knee osteoarthritis induced by monosodium iodoacetate. J Inflamm Res. 2021;14:3247\u201359.","journal-title":"J Inflamm Res"},{"issue":"10","key":"1276_CR61","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/14728222.2024.2416961","volume":"28","author":"A Mobasheri","year":"2024","unstructured":"Mobasheri A, Rannou F, Ivanavicius S, Conaghan PG. Targeting the TRPV1 pain pathway in osteoarthritis of the knee. Expert Opin Ther Targets. 2024;28(10):843\u201356.","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"1276_CR62","doi-asserted-by":"publisher","first-page":"509","DOI":"10.7326\/M20-0527","volume":"173","author":"M Schieker","year":"2020","unstructured":"Schieker M, Conaghan PG, Mindeholm L, Praestgaard J, Solomon DH, Scotti C, et al. Effects of interleukin-1\u03b2 inhibition on incident hip and knee replacement. Ann Intern Med. 2020;173(7):509\u201315.","journal-title":"Ann Intern Med"},{"issue":"11","key":"1276_CR63","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.joca.2010.08.016","volume":"18","author":"O Stannus","year":"2010","unstructured":"Stannus O, Jones G, Cicuttini F, Parameswaran V, Quinn S, Burgess J, et al. Circulating levels of IL-6 and TNF-\u03b1 are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage. 2010;18(11):1441\u20137.","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"1276_CR64","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/annrheumdis-2011-201047","volume":"72","author":"OP Stannus","year":"2013","unstructured":"Stannus OP, Jones G, Blizzard L, Cicuttini FM, Ding C. Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann Rheum Dis. 2013;72(4):535\u201340.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1276_CR65","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/rheumatology\/37.5.502","volume":"37","author":"RJ Dolhain","year":"1998","unstructured":"Dolhain RJ, Tak PP, Dijkmans BA, De Kuiper P, Breedveld FC, Miltenburg AM. Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Rheumatology. 1998;37(5):502\u20138.","journal-title":"Rheumatology"},{"issue":"4","key":"1276_CR66","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/03009740600588186","volume":"35","author":"Y Morita","year":"2006","unstructured":"Morita Y, Fukazawa T, Hirashima M, Kaga K, Kusaoi M, Morita T, et al. The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production. Scand J Rheumatol. 2006;35(4):268\u201372.","journal-title":"Scand J Rheumatol"},{"issue":"534","key":"1276_CR67","first-page":"7","volume":"57","author":"K Jordan","year":"2007","unstructured":"Jordan K, Clarke AM, Symmons DPM, Fleming D, Porcheret M, Kadam UT, et al. Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases. Br J Gen Pract. 2007;57(534):7\u201314.","journal-title":"Br J Gen Pract"},{"issue":"7","key":"1276_CR68","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/rheumatology\/keq332","volume":"50","author":"G Peat","year":"2011","unstructured":"Peat G, Birrell F, Cumming J, Doherty M, Simpson H, Conaghan PG. Under-representation of the elderly in osteoarthritis clinical trials. Rheumatology. 2011;50(7):1184\u20136.","journal-title":"Rheumatology"},{"issue":"4","key":"1276_CR69","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11136-014-0820-7","volume":"24","author":"RE Mujica-Mota","year":"2015","unstructured":"Mujica-Mota RE, Roberts M, Abel G, Elliott M, Lyratzopoulos G, Roland M, et al. Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. Qual Life Res. 2015;24(4):909\u201318.","journal-title":"Qual Life Res"},{"issue":"7","key":"1276_CR70","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/acr.24008","volume":"72","author":"S Swain","year":"2020","unstructured":"Swain S, Sarmanova A, Coupland C, Doherty M, Zhang W. Comorbidities in osteoarthritis: a systematic review and meta\u2010analysis of observational studies. Arthritis Care Res. 2020;72(7):991\u20131000.","journal-title":"Arthritis Care Res"},{"issue":"mar08 2","key":"1276_CR71","doi-asserted-by":"publisher","first-page":"d1165-d","DOI":"10.1136\/bmj.d1165","volume":"342","author":"E Nuesch","year":"2011","unstructured":"Nuesch E, Dieppe P, Reichenbach S, Williams S, Iff S, Juni P. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ. 2011;342(mar08 2):d1165-d.","journal-title":"BMJ"},{"issue":"902","key":"1276_CR72","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/pgmj.76.902.787","volume":"76","author":"B Hirshberg","year":"2000","unstructured":"Hirshberg B. Safety of low dose methotrexate in elderly patients with rheumatoid arthritis. Postgrad Med J. 2000;76(902):787\u20139.","journal-title":"Postgrad Med J"},{"key":"1276_CR73","doi-asserted-by":"crossref","unstructured":"Enteshari-Moghaddam A, Isazadehfar K, Habibzadeh A, Hemmati M. Efficacy of methotrexate on pain severity reduction and improvement of quality of life in patients with moderate to severe knee osteoarthritis. Anesthesia Pain Med. 2019;9(3).","DOI":"10.5812\/aapm.89990"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-025-01276-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:02:45Z","timestamp":1772125365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-025-01276-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1276"],"URL":"https:\/\/doi.org\/10.1007\/s40266-025-01276-4","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MDCF, FP, KF, PGC, SRK have no conflicts of interest related to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (Participation and Publication)"}},{"value":"Data sharing not applicable to this article as no datasets were generated or analysed during the current study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"MDCF and SRK conducted the literature review and wrote the first draft of the manuscript. FP, KF and PGC critically revised and added extra text. All authors read and approved the final manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}